Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the
Coronavirus family which caused the worldwide pandemic of human respiratory illness …

Introduction The willingness of Africa's population to patronise the COVID-19 vaccines is
critical to the efficiency of national immunisation programmes. This study surveys the views …

SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which
effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of the host cell …

A virus outbreak challenges the economic, medical, and public health infrastructure
worldwide. More than one virus capable of triggering diseases have been identified per year …

Background Because COVID-19 case data do not capture most SARS-CoV-2 infections, the
actual risk of severe disease and death per infection is unknown. Integrating …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
COVID-19 pandemic. Currently, as dangerous mutations emerge, there is an increased …

Our study was carried out to characterize respiratory tract microbiota in patients with “COVID-
like pneumonia” in Kazakhstan and analyze differences between COVID-19 positive and …

The coronavirus SARS-CoV-2 is the cause of the ongoing COVID-19 pandemic. Most SARS-
CoV-2 infections are mild or even asymptomatic. However, a small fraction of infected …

A major complication in COVID-19 infection consists in the onset of acute respiratory distress
fueled by a dysregulation of the host immune network that leads to a run-away cytokine …

Introduction The administration of systemic corticosteroids is a key strategy for improving
COVID-19 outcomes. However, evidence is lacking on combination therapies of antiviral …